Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III double-blind randomized trial of JDSJ ointment for deep partial-thickness burns
CTR20262876Phase 3Active
- Sponsor
- Guangxi Huahong Pharmaceutical
- Start
- Jul 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Jiedu Shengji in cutaneous burn, sponsored by Guangxi Huahong Pharmaceutical. Started Jul 2026; status: active.
02
Drugs
Jiedu Shengji
03
Conditions
cutaneous burn
Beyond the preview
Go deeper on CTR20262876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262876.